About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts

Press Releases

2017 2018 2019
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005


  December 2016
27 Dec  Journal of the American Medical Association  (JAMA) Publishes Mylan and Biocon's  Proposed Biosimilar Trastuzumab Phase 3  Data Download Pdf
09 Dec  Biocon Features in Asia IP Elite 2016 List Download Pdf
  November 2016
29 Nov  Biocon's Novel Diabetes Education Initiative  for Medical Practitioners 'ABIDE' Awarded  by RSSDI Download Pdf
11 Nov  Biocon Collaborates with Healthcare  Professionals for a Public Awareness  Campaign on Diabetes Prevention &  Management Across India Download Pdf
08 Nov  Mylan and Biocon Announce U.S. FDA  Submission for Proposed Biosimilar  Trastuzumab Download Pdf
03 Nov  Mylan and Biocon Announce Regulatory  Submission for Insulin Glargine Accepted  for Review by European Medicines Agency Download Pdf
  October 2016
28 Oct  Biocon Ranked Among Global Top Ten  Biotech Employers; The only Asian  Company to Feature in 2016 Rankings Download Pdf
20 Oct  Biocon Q2 FY17 Revenue Up 21%
 EBITDA Up 45% Revenues at Rs 992 Crs.;  EBITDA at Rs 277 Crs.; Net Profit at Rs 147  Crs.
Download Pdf
  September 2016
19 Sep  Biocon Appoints Suresh Subramanian as  Head of Branded Formulations (India)  Business Download Pdf
01 Sep

 Kiran Mazumdar Shaw Appointed 'Knight of  the Legion of Honour' by the Government of  France

Download Pdf
 August 2016
25 Aug

 Mylan and Biocon Announce Regulatory  Submission for Proposed Biosimilar  Trastuzumab Accepted for Review by  European Medicines Agency

Download Pdf
  July 2016
28 July

 Biocon Initiates "Ek Prayaas" Nationwide  Awareness Program on Hepatitis C

Download Pdf
21 July

 Biocon Reports a Strong Q1FY17
 Revenues at Rs 952 Crore, up by 11 %;  EBITDA Up 15% to Rs 271 Crore
 Net Profit Up 17% at Rs 147 Crore

Download Pdf
21 July

 Mylan & Biocon Announce Regulatory  Submission for Proposed Biosimilar  Pegfilgrastim Accepted for Review by  European Medicines Agency

Download Pdf
15 July

 Biocon's Insulin Glargine Launched in Japan

Download Pdf
  June 2016
23 Jun  Biocon, Quark Announce Initiation of Pivotal  Phase II/III Study of QPI-1007 in Rare Eye  Disease in India Download Pdf
04 Jun  Mylan and Biocon to Present Phase 3  Trastuzumab Biosimilar Data at the  American Society of Clinical Oncology  (ASCO) Annual Meeting Download Pdf

  April 2016
26 Apr  Biocon Q4FY16 Net Profit at Rs 361 Cr  Revenue Crosses Rs 1,000 Cr; Up 17% FY  16 Revenues up 14% at Rs 3,570 Cr  Net  Profit at Rs 896 Cr Download Pdf

  March 2016
28 Mar  Biocon's Insulin Glargine Receives
 Regulatory Approval in Japan
Download Pdf
17 Mar  Biocon Inks Co-Development &
 Commercialization Agreement with Lab
 PiSA for rh- Insulin in USA
Download Pdf

  February 2016
15 Feb  Biocon Gets its First Generic Formulation
 Approval in EU; On Track to Launch
 Rosuvastatin Tablets in FY 17
Download Pdf

  January 2016
21 Jan  Biocon Q3FY16 Net Profit Up 13% at Rs 103
 Crore, EBITDA Increases 23% to Rs 209
 Crore, Revenues at Rs 857 Crore, up by
Download Pdf
21 Jan  Biocon Announces Data from Key Studies
 for Insulin Tregopil
Download Pdf




Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved